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AbstrAct
Radiotherapy is being performed in many situations as a curative approach for head and neck cancer instead of surgery due 
to the current novel coronavirus disease (cOVID-19) pandemic. A recent publication reported that even hypofractionation was 
being conducted in order to reduce the daily exposure of both patients and the medical staff involved in cancer therapies. 
As a result, dental teams may be requested more frequently than usual to fabricate intraoral stents (IOS). Given that IOS may 
be a potential source of cOVID-19 contagion, the main purpose of the present correspondence is to offer a guide on how 
health professionals may be safely presented in the room, on the management of the IOS and also how to sanitize the stents.
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It is known that the outbreak of the novel coro-
navirus disease (COVID-19) has created difficult 
challenges for oncology clinicians in managing and 
treating cancer patients due to the estimated higher 
risk such individuals have of contracting the virus. 
Because of the absence of international guidelines 
on conducting cancer treatment during an infectious 
pandemic, health-care settings are postponing “elec-
tive” cancer treatments, which may be understood 
as newly diagnosed tumors with low proliferation 
rates receiving less intense chemotherapy and/or 
radiotherapy [1]. For example, head and neck can-
cer services have rescheduled surgical procedures 
in order to reduce the exposure of patients and the 
medical team to the risk of COVID-19 contagion [2]. 
These strategies also aim to reduce hospital length 
of stay, preserving clinical capacity for COVID-19 
patients, which is understood to be a necessary ap-
proach given the number of patients with confirmed 
COVID-19 infection who will be referred and ad-
mitted to the majority of hospitals worldwide during 
the ongoing public health emergency. 
However, a group of authors recently published 
an editorial letter suggesting that the postpone-
ment of cancer treatment should be avoided since 
such deferred care may negatively impact patients’ 
survival. They also recommend that radiotherapy 
is more indicated for patients with tumors located 
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in the upper aerodigestive tract if tracheostomy is 
required (due to the risk of COVID-19 infection, 
dissemination, respiratory complications, and 
possibly death) and also in the case of the unavail-
ability of operating rooms, which are being used 
in many countries as ICUs [1]. These authors also 
suggest that a shorter regimen of radiation (hy-
pofractioned) is recommended in order to reduce 
the daily exposure of both patients and medical 
staff involved in cancer therapies/treatment, with-
out compromising control of locoregional disease 
progression or increasing toxicities [1]. Therefore, 
it can be expected that patients will probably be 
referred more often to the radiotherapy team. 
Consequently, the dental team may be requested 
more frequently than usual to fabricate prosthetic 
stents — also called intraoral stents (IOS) — for 
radiotherapy. 
Given that dentists will probably be exposed to 
almost all possible routes for COVID-19 infection 
(aerosols, droplets, contact with contaminated ma-
terials, dental instruments and/or surfaces) [3, 4], 
coupled with the fact that (1) pathogenic microor-
ganisms can be suspended in the air for long peri-
ods [4], (2) the incubation period — from 1 to 14 
days, approximately — may not induce symptoms 
in infected patients but still turn them into a signifi-
cant source of spreading, and also (3) the progres-
sive increase in the number of infected individuals 
(daily updates can be verified at https://www.who.
int/emergencies/diseases/novel-coronavirus-2019), 
it is urgent to protect patients and staff members by 
means of sharing clinical expertise and skills. This 
strategy is useful in creating guidelines for reducing 
exposure to the COVID-19 virus during the perfor-
mance of nonelective procedures [1].
Needless to say, the current scenario does not 
allow the validation of all management suggestions 
by means of a scientific clinical trial or investigative 
research, whereas health professionals are demand-
ing reliable information. Therefore, the present let-
ter has the main goal of providing strategies based 
on guidelines that were developed by radiation on-
cologists, infectologists and dental teams of one 
cancer institution in Brazil (Instituto do Câncer 
do Estado de São Paulo — ICESP), and also on the 
recommendations from the World Health Organi-
zation (WHO) [5].
Figure 1 summarizes all the scripts described 
herein. A patient with confirmed or suspected CO-
VID-19 should be conducted to the radiotherapy 
equipment by two professionals who should be 
wearing full personal protective equipment (PPE) 
— disposable doctor cap, goggles, oil non-resistant 
air-purifying respirators with 95% efficiency (N95) 
covered by a disposable American Society for Test-
ing and Materials (ASTM) level 3 surgical mask, face 
shield and disposable gloves, among others. After 
IOS and patient positioning, one of the professionals 
should remove his/her PPE and perform the treat-
ment while the second professional waits outside the 
radiation room, still wearing their PPE. Next, the 
individual wearing the PPE should remove the stent 
and equipment and sanitize the prosthetic device.
It is important to discuss that there is no evi-
dence supporting the use of a particular solution for 
sanitizing acrylic material but Peng et al. [3] recom-
mend the use of 0.5% hydrogen peroxide (H2O2) 
or ≈70% alcohol for killing the COVID-19 virus. 
Therefore, the authors of the present letter suggest 
the use of disposable brushes with soap followed 
by abundant washing with water. After drying with 
disposable paper, 0.5% hydrogen peroxide or ≈70% 
alcohol should be sprayed onto the IOS for 1 min 
and cleaned. Finally, the IOS should be stored in 
a proper box that allows airflow. 
One of the goals of the present letter is to avoid the 
situation radiotherapists not requesting IOS fabrica-
tion during the COVID-19 pandemic because of the 
risk of contagion, as discussed above. In this context, 
it is important to consider that Chaves et al. [1] sug-
gested that multidisciplinary support must be main-
tained during patient’s treatment and that IOS may 
reduce the incidence and severity of an important 
acute toxicity related to radiation: oral mucositis. It is 
known that this complication can negatively impact 
patients’ outcomes (such as: pain, inability to eat 
with requirement for feeding tubes, and weight loss), 
increasing resource usage (drugs, hospitalization, for 
example) [6], and consequently, may facilitate infec-
tion with COVID-19 and mortality.
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Figure 1. Scheme summarizing all the information necessary for the safe manipulation of intraoral stents during the 
radiation treatment. 1 — patient arrives in the radiotherapy room; 2 — during radiotherapy session: * door of the hospital 
room should be closed with low pressure inside in cases of suspected or confirmed cOVID-19; ** one radiation technician 
should remove disposable protective equipment and wait outside the hospital room during the radiation treatment; *** 
Patients with tracheostomy should have their tracheal cannula covered with a disposable surgical mask because this could 
become a relevant infection route if the individual coughs, secreting fluids, during the session. It is also very important 
that professionals sanitize their hands with water and soap or alcohol gel before the patient examination, before dental 
procedures, after touching the patient, after touching equipment without disinfection, and after touching the oral mucosa or 
body fluids [3]. 3 — patient leaves the radiotherapy room
